Your browser doesn't support javascript.
loading
Rosiglitazone reduces diabetes angiopathy by inhibiting mitochondrial dysfunction dependent on regulating HSP22 expression.
Yu, Lingling; Chen, Shengsong; Liang, Qian; Huang, Chahua; Zhang, Weifang; Hu, Longlong; Yu, Yun; Liu, Liang; Cheng, Xiaoshu; Bao, Huihui.
Afiliación
  • Yu L; Department of Rehabilitation, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
  • Chen S; Department of Cardiology, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
  • Liang Q; Department of Pulmonary and Critical Care Medicine, Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang 330006, China.
  • Huang C; Department of Public Health, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
  • Zhang W; Department of Cardiology, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
  • Hu L; Department of Pharmacy, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
  • Yu Y; Department of Cardiology, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
  • Liu L; Department of Cardiology, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
  • Cheng X; Department of Cardiology, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
  • Bao H; Department of Cardiology, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
iScience ; 26(4): 106194, 2023 Apr 21.
Article en En | MEDLINE | ID: mdl-36968091
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: IScience Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: IScience Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos